Clinical Trial Update: FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial comparing five consecutive days on ART (efavirenz, tenofovir, emtricitabine) followed by two days off versus continuous treatment in HIV infection…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• efavirenz/tenofovir/emtricitabine combination (Atripla/STRs used in regimen)

Snippet

Sponsor: Community Research Initiative of New England | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2011-01-04